Cipaglucosidase alfa-atga: Unveiling new horizons in Pompe disease therapy
Pompe disease is a lysosomal storage disease characterized by impaired glycogen breakdown due to an acid α-glucosidase (GAA) enzyme deficiency. Without therapy, children with the severe infantile form do not survive past their first year of life. POMBILITI which is intended to treat late-onset Pompe...
Salvato in:
| Autori principali: | , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2024-06-01
|
| Serie: | Health Sciences Review |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2772632024000138 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|